A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Clinical trial NCT04584112 · COMPLETED
Trial details
- NCT number
- NCT04584112
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2023-03-08
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.